Publications


2023

Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer.

Wichert K, Hoppe R, Ickstadt K, Behrens T, Winter S, Herold R, Terschüren C, et al.


Eur J Epidemiol
202310
https://pubmed.ncbi.nlm.nih.gov/37789226/

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. 

Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, et al.


J Med Genet
202309
https://pubmed.ncbi.nlm.nih.gov/27595995/

Influence of mammographic density and compressed breast thickness on true mammographic sensitivity: a cohort study.

Strandberg R, Illipse M, Czene K, Hall P, Humphreys K.


Sci Rep
202308
https://pubmed.ncbi.nlm.nih.gov/37648804/

A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.

Middha P, Wang X, Behrens S, Bolla MK, Wang Q, Dennis J, Michailidou K, Ahearn TU, et al.


Breast Cancer Res
202308
https://pubmed.ncbi.nlm.nih.gov/37559094/

FGF/FGFR1 system in paired breast tumor-adjacent and tumor tissues, associations with mammographic breast density and tumor characteristics.

Boraka Ö, Klintman M, Vallon-Christersson J, Zackrisson S, Hall P, Borgquist S, Rosendahl AH.


Front Oncol.
202307
https://pubmed.ncbi.nlm.nih.gov/37546410/

Evaluation of SNPs associated with mammographic density in European women with mammographic density in Asian women from South-East Asia.

Mariapun S, Ho WK, Eriksson M, Tai MC, Mohd Taib NA, Yip CH, Rahmat K, Li J, Hartman M, Hall P, et al.


Epub
202306
https://pubmed.ncbi.nlm.nih.gov/37338730/

A Clinical Risk Model for Personalized Screening and Prevention of Breast Cancer.

Eriksson M, Czene K, Vachon C, Conant EF, Hall P.


Cancers (Basel)
202306
https://pubmed.ncbi.nlm.nih.gov/37370856/

Novel predictions of invasive breast cancer risk in mammography screening cohorts.

Strandberg R, Czene K, Hall P, Humphreys K.


Epub
202306
https://pubmed.ncbi.nlm.nih.gov/37337390/

Studying the association between longitudinal mammographic density measurements and breast cancer risk: a joint modelling approach.

Illipse M, Czene K, Hall P, Humphreys K.


Breast Cancer Res
202306
https://pubmed.ncbi.nlm.nih.gov/37296473/

Effects of tamoxifen on normal breast tissue histological composition: Results from a randomised six-arm placebo-controlled trial in healthy women.

Gabrielson M, Hammarström M, Bäcklund M, Bergqvist J, Lång K, Rosendahl AH, Borgquist S, Hellgren R, Czene K, Hall P.


Int J Cancer
202306
https://pubmed.ncbi.nlm.nih.gov/36637153/

Prediction of breast cancer risk for sisters of women attending screening.

Mao X, He W, Eriksson M, Lindström LS, Holowko N, Bajalica-Lagercrantz S, Hammarström M, Grassmann F, Humphreys K, Easton D, Hall P, Czene K.


J Natl Cancer Inst
202305
https://pubmed.ncbi.nlm.nih.gov/37243694/

Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women

Hammarström M, Gabrielson M, Crippa A, Discacciati A, Eklund M, Lundholm C, Bäcklund M, Wengström Y, Borgquist S, Bergqvist J, Eriksson M, Tapia J, Czene K, Hall P.


BJC
202305
https://pubmed.ncbi.nlm.nih.gov/37149701/

Long-Term Performance of an Image-Based Short-Term Risk Model for Breast Cancer.

Eriksson M, Czene K, Vachon C, Conant EF, Hall P.


J Clin Oncol
202305
https://pubmed.ncbi.nlm.nih.gov/36930854/

Clinical biomarker-based biological aging and risk of cancer in the UK Biobank.

Mak JKL, McMurran CE, Kuja-Halkola R, Hall P, Czene K, Jylhävä J, Hägg S.


Epub
202304
https://pubmed.ncbi.nlm.nih.gov/37120669/

A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31.

Barnekow E, Hasslow J, Liu W, Bryant P, Thutkawkorapin J, Wendt C, Czene K, Hall P, Margolin S, Lindblom A.


Int J Mol Sci
202302
https://pubmed.ncbi.nlm.nih.gov/36901898/

Factors Associated With False-Positive Recalls in Mammography Screening.

Mao X, He W, Humphreys K, Eriksson M, Holowko N, Strand F, Hall P, Czene K.


J Natl Compr Canc Netw
202302
https://pubmed.ncbi.nlm.nih.gov/36791753/

Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Breast Cancer: Evidence from a General Female Population and a Mammographic Screening Cohort in Sweden

Kejia Hu, Maria Feychting, Donghao Lu, Arvid Sjölander, Kamila Czene, Per Hall, Fang Fang.


Cancers (Basel)
202301
https://pubmed.ncbi.nlm.nih.gov/36765650/

A Randomized Controlled Trial of Soy Isoflavone Intake on Mammographic Density among Malaysian Women.

Rajaram N, Yap B, Eriksson M, Mariapun S, Tan LM, Sa’at H, Ho ELM, Taib NAM, Khor GL, et al.


Nutrients
202301
https://pubmed.ncbi.nlm.nih.gov/36678170/

Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Breast Cancer: Evidence from a General Female Population and a Mammographic Screening Cohort in Sweden.

Hu K, Feychting M, Lu D, Sjölander A, Czene K, Hall P, Fang F.


Cancer (Basel)
202301
https://pubmed.ncbi.nlm.nih.gov/36765650/

2022

Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study.

Yang X, Eriksson M, Czene K, Lee A, Leslie G, Lush M, Wang J, Dennis J, Dorling L, Carvalho S, Mavaddat N, Simard J, Schmidt MK, Easton DF, Hall P, Antoniou AC.


J Med Genet
202212
https://pubmed.ncbi.nlm.nih.gov/36162852/